NEETPGAI
BlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Microbiology/Complement System
    Complement System
    easy
    bug Microbiology

    Which of the following complement components is the most potent anaphylatoxin and is generated by all three complement pathways?

    A. C3a
    B. C2a
    C. C4a
    D. C5a

    Explanation

    ## Anaphylatoxins and Their Potency **Key Point:** C5a is the most potent anaphylatoxin generated during complement activation, produced by all three pathways (classical, alternative, and lectin). ### Anaphylatoxin Hierarchy | Component | Potency | Source Pathways | Primary Effects | | --- | --- | --- | --- | | C5a | **Most potent** | All three | Chemotaxis, mast cell degranulation, increased vascular permeability | | C3a | Moderate | All three | Mast cell degranulation, smooth muscle contraction | | C4a | Weak | Classical, Lectin | Minimal anaphylactic activity | | C2a | Negligible | Classical, Lectin | No anaphylactic activity | **High-Yield:** C5a is ~200-fold more potent than C3a in inducing mast cell degranulation and is the primary driver of complement-mediated inflammation. ### Mechanism of C5a Action 1. Binds to C5a receptors (C5aR1 and C5aR2) on mast cells, neutrophils, and endothelial cells 2. Triggers G-protein coupled receptor signaling 3. Causes release of histamine, tryptase, and inflammatory mediators 4. Increases vascular permeability and smooth muscle contraction 5. Promotes neutrophil chemotaxis and activation **Clinical Pearl:** Excessive C5a generation is implicated in sepsis-induced shock, acute respiratory distress syndrome (ARDS), and anaphylaxis. C5a inhibitors (e.g., eculizumab) are used therapeutically in complement-mediated diseases. **Mnemonic:** **C5a = Catastrophic anaphylatoxin** — remember it as the "5-star" inflammatory mediator.

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Microbiology Questions